David L. Cooper, CEO of PhytoDental Solutions, comments on the publication of the first prospective human clinical trial using a CBD rich Full Spectrum Hemp Oil in patients with COVID-19.

April 1, 2022 | Press Releases

Recently, Med 7 LLC, and HempCo Inc., announce the publication of the first prospective human clinical trial using a CBD rich Full Spectrum Hemp Oil in patients with COVID-19.

“These findings are very relevant since cytokine levels and WBC counts on admission significantly correlate with death in COVID patients,” according to David Cooper, MD, PhD, one of the authors of the study.

“There have been two recently published studies on the effects of CBD and other cannabinoids on COVID. These studies are important in looking at the effects of cannabinoids on COVID replication and cellular entry,” continued Cooper.

“Both of these previous studies were conducted on human and primate cell lines in laboratories. This current study is the first randomized prospective study of a CBD rich product in human subjects with active COVID infection.”

About PhytoDental Solutions

PhytoDental Solutions (“PDS”) is dedicated to developing phytocannabinoid-based and augmented formulations for applications across the spectrum of dental diseases and surgical procedures, to provide patients with products of special effect for daily oral care, and at the same time, introducing advanced technology to build a system of precision dentistry to systematically solve the long-standing pain points in the dental and health management industries.

PDS provides a series of professional and consumer products including clinically and statistically validated indication specific formulation products for dental anxiety, denture stomatitis, orthodontic caries and gingivitis, periodontitis, peri-implantitis, pre-, post- dental surgical care, and anti-inflammatory consumer products including toothpaste, dental floss, mouthwash and a series of dental appliances for home use.

PDS indication special formulations are capable of forming a powerful supplement or even replacement for the obvious clinical defects of most products in the dental market.

By promoting the precise application of cannabinoids in dentistry to block the common "oral entrance of pathogens", the systemic health of patients is improved, and an innovative new model of health management - "Dental Health is Well Health" created.